DISHMAN

DISHMAN · NSE · inactive

301.20

+7.95 (+2.71%)

as of 29 May 2017 close

Open

288.20

High

304.20

Low

278.00

Prev close

293.25

52w high

347.00

17 Apr 2017

52w low

127.95

24 Jun 2016

VWAP

295.50

Delivery %

32.7%

of volume

Volume 16.16 L · turnover ₹47.74 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 22 Apr 2004

Series: EQ
F&O: No
Status: Inactive since 29 Apr 2017

Source: NSE equity master · as of 28 Apr 2017

Daily · NSE EOD

Exchange announcements

Source: NSE corporate filings · latest Today 10:07 IST

All M&A AGM / meeting Analyst meet Board meeting Business update Management Compliance Corporate action Credit rating Dividend Exchange query General update Insider / SAST Legal Order win Results

17 May 2017 16:17
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Investor Presentation
PDF · -
15 May 2017 12:43
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
PDF · -
08 Mar 2017 12:46
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
PDF · -
14 Feb 2017 14:24
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Investor Presentation
PDF · -
13 Feb 2017 15:52
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
PDF · -
05 Nov 2016 14:54
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
PDF · -
28 Oct 2016 14:23
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange a copy of INVESTORS PRESENTATION ON UNAUDITED FINANCIAL RESULT REGULATION: 30
PDF · -
27 Oct 2016 15:22
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Intimation of Conference Call.
PDF · -
20 Oct 2016 11:57
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Intimation of Conference Call.
PDF · -
13 Aug 2016 12:11
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Transcript of Conference Call - Quarter Ended June 30, 2016.
PDF · -
04 Aug 2016 13:25
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange a copy of the Investors Presentation on Unadudited Financial Results for the Quarter ended June 30, 2016.
PDF · -
04 Aug 2016 11:43
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Re-Schedulement of the Conference Call.
PDF · -
03 Aug 2016 14:16
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding the Intimation of Conference Call.
PDF · -
05 Feb 2016 15:33
Analyst meet
Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Company has arranged Conference Call with Investors on February 08, 2016 to discuss the financial result and performance of the Company for the quarter ended December 31, 2015.
PDF · -

Coming next in news

Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.

Results & board-meeting calendar
Dividend, split, AGM calendar
Headlines with source and timestamp
Two-line factual filing summaries